 |
|
|
| |
Changes in Truvada® for HIV Pre-exposure
Prophylaxis Utilization in the USA: 2012-2016 - Disparities
|
| |
| |
Reported by Jules Levin
19th IAS Conference on HIV Science, 23-26 July 2017, Paris, France
Robertino Mera, David Magnuson, Trevor Hawkins, Staci Bush, Keith Rawlings, Scott
McCallister
Gilead Sciences, Inc., Foster City, California, USA
References
1. Just Facts. www.justfacts.com/document/lifetime_risk_hiv.pdf;
2. Smith D, et al. MMWR Morb Mortal Wkly Rep 2015;64:1-6;
3. Mera-Giler R,
et al. 2015 National HIV Prevention Conference, abstr 1524;
4. Bush S, et al. ASM/ICAAC 2016, abstr 2651;
5. US Census Bureau. https://www.census.gov/quickfacts/table/PST045215/00;
6. Kaiser Family Foundation. http://kff.org/hivaids/fact-sheet/black-americans-and-hivaids-the-basics.
|
| |
|
|
|
|
|
